Korean Biotech Database

The CHMP positive opinion is based on data from a global clinical trial program conducted by SK life science, a subsidiary of SK Biopharmaceuticals;Cenobamate will now be referred to the European Commission for final approval, an important step towards launching as a new treatment option for the... Read more ››

By: PR Newswire Association LLC. - 29 Jan 2021

Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA

By: PR Newswire Association LLC. - 28 Jan 2021

Related companies: ImmunoForge

South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis

By: PR Newswire Association LLC. - 27 Jan 2021

Related companies: Lunit Inc.

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

By: PR Newswire Association LLC. - 27 Jan 2021

Related companies: Samsung Biologics Co., Ltd.

Sanofi: Information concerning the total number of voting rights and shares - December 2020

By: GlobenewsWire - 26 Jan 2021

Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

By: PR Newswire Association LLC. - 26 Jan 2021

Related companies: Samsung Biologics Co., Ltd.

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 25 Jan 2021

Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes

By: GlobenewsWire - 20 Jan 2021

Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs

By: PR Newswire Association LLC. - 18 Jan 2021

Related companies: Hanmi Pharmaceutical Co., Ltd.

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 18 Jan 2021

Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference

By: PR Newswire Association LLC. - 13 Jan 2021

Related companies: Samsung Biologics Co., Ltd.

Hanmi presents solution package strategy to potentially overcome COVID-19 at the 39th JP Morgan Healthcare Conference

Hanmi Pharmaceutical Co., Ltd. develops a full package strategy to potentially handle the COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine);Recently releases Hanmi Cold-Mask™(nasal spray) and on preparation to release COVID-19 & Influenza dual diagnostic kit Read more ››

By: PR Newswire Association LLC. - 13 Jan 2021

Related companies: Hanmi Pharmaceutical Co., Ltd.

SANOFI unveils EUROAPI as the name of the new industry leading European API* company and appoints Karl Rotthier as its future Chief Executive Officer

By: GlobenewsWire - 12 Jan 2021

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 11 Jan 2021

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Korea?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2021
- NLSDays + NLS Invest Digital - Nordic Life Science Days
- Greater Copenhagen Microbiome Summit 2021
- 4th Annual Neuroscience Innovation Forum

See Events »

Add an Event »

Latest company news

Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
16 Apr 2021 (PR Newswire Association LLC.)

Novo Nordisk A/S – Share repurchase programme
12 Apr 2021 (GlobenewsWire)

PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021
12 Apr 2021 (PR Newswire Association LLC.)

News in the Life Sciences Industry

Looking for companies outside of Korea?

Partners

Upcoming Life Sciences Events

Latest company news